Sarepta Therapeutics, Inc. (SRPT)

16.64 -0.52 (-3.00%) USD  |  NASDAQ  |  Mar 19, 16:00
16.76 +0.12 (+0.69%) After-Hours: 20:00
More

Sarepta Therapeutics EPS LT Growth Estimates

EPS LT Growth Estimates Chart

View EPS LT Growth Estimates for SRPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS LT Growth Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS LT Growth Estimates Range, Past 5 Years

View EPS LT Growth Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS LT Growth Estimates Benchmarks

View EPS LT Growth Estimates Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
REGENXBIO, Inc. --
Keros Therapeutics, Inc. --
Gilead Sciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --